RSD921: NRT will begin in August a Brazilian trial in healthy volunteers

Nortran Pharmaceuticals Inc., Vancouver, B.C. Product: RSD921, small molecule ion channel blocker Indication: Cardiovascular arrhythmia Status: NRT will begin in August a Brazilian trial in healthy vo...